Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRT6005 analgesic in painful diabetic polyneuropathy
2008-004794-18Phase 2Completed
- Sponsor
- Grünenthal GmbH
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cebranopadol in diabetic polyneuropathy (DPN) (3 arms), sponsored by Grünenthal GmbH. Started Nov 2008; status: completed.
02
Drugs
cebranopadol
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on 2008-004794-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004794-18.